Zusammenfassung
Die intraaortale Ballonpumpe (IABP) führt zu einer Verbesserung der Hämodynamik bei Patienten mit kardiogenem Schock. Nach der derzeitigen Datenlage ist eine Anwendung bei Patienten ohne frühzeitige perkutane Koronarintervention (PCI) oder geplante operative Revaskularization sowie bei Patienten mit mechanischen Komplikationen des akuten Herzinfarkts zu empfehlen. Sie sollte möglichst frühzeitig erfolgen. Inwieweit eine generelle Anwendung der IABP bei frühzeitiger primärer PCI sinnvoll ist, wird derzeit in der IABP-Shock-II-Studie geprüft.
Abstract
The use of intra-aortic balloon pumps (IABP) leads to an improvement in the hemodynamics in patients with cardiogenic shock. According to the current state of knowledge the use is recommended for patients without timely percutaneous coronary intervention (PCI) or planned operative revascularization and patients with mechanical complications of acute heart attack. The IABP should be implanted as early as possible after onset of shock. Wether a general use in all patients with shock treated with primary PCI is currently under investigation in the IABP Shock II trial.
Literatur
Babaev A, Frederick PD, Pasta DJ et al (2005) Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294:448–454
Mehlhorn E, Vivie ER de (2001) Mechanische Herzunterstützung mit der intraaortalen Ballonpumpe. Dtsch Arztebl 98:2653–2658
Nanas JN, Moulopoulos SD (1994) Counterpulsation: historical background, technical improvements, hemodynamic and metabolic effects. Cardiology 84:156–167
Ferguson JJ, Cohen M, Freedman RJ et al (2001) The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 38:1456–1462
Stone GW, Ohman EM, Miller MF et al (2003) Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol 41(11):1940–1945
Hochman JS, Sleeper LA, Webb JG et al (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625–634
Kovack PJ, Rasak MA, Bates ER et al (1997) Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 29:1454–1458
Sanborn TA, Sleeper LA, Bates ER et al (2000) Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol 36:1123–1129
Barron HV, Every NR, Parsons LS et al (2001) The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 141:933–939
Sjauw KD, Engstrom AE, Vis MM et al (2009) A systematic review and meta-analysis of intra aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30:459–468
Antman EM, Anbe TE, Armstrong PW et al (2004) ACC/AHA guidelines for the management of patients with ST-segment elevation myocardial infarction. Circulation 110:e82–e293
Van de Werf F, Bax J, Betriu A et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 23:2909–2945
Werdan K, Ruß M, Buerke M et al (2011) Deutsch-österreichische S3 Leitlinie: Infarktbedingter kardiogener Schock: Diagnostik, Monitoring und Therapie. Intensivmed Notfallmed 48:291–344
Zeymer U, Bauer T, Hamm C et al (2011) Use and impact of intra aortic balloon pump on outcome in patients with acute myocardial infarction complicated by cardiogenic shock. Results of the Euro Heart Survey on PCI. EURO Intervention (in press)
Zeymer U, Zahn R, Hochadel M et al (2010) Use and impact of intra aortic balloon pump on outcome in patients with PCI for myocardial infarction complicated by cardiogenic shock. Results of the ALKK-PCI Registry. Eur Heart J 31:897 (Abstract Suppl)
Hollenberg SM (2004) Recognition and treatment of cardiogenic shock. Semin Respir Crit Care Med 25(6):661–671
Zeymer U, Vogt A, Zahn R et al (2004) Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI). Eur Heart J 25:322–328
Ohman EM, Hochman JS (2001) Aortic counterpulsation in acute myocardial infarction: physiologically important but does the patient benefit? Am Heart J 141:889–892
Prodzinsky R, Lemm H, Swyter M et al (2010) Intra-aortic Balloon Counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock – the prospective, randomised IABP SHOCK trial for attenuation of multi-organ dysfunction syndrome. Crit Care Med 38:152–160
Thiele H, Schuler G (2009) Cardiogenic shock: to pump or not to pump? Eur Heart J 30:389–390
Interessenkonflikt
Keine Angaben.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zeymer, U., Thiele, H. & Zahn, R. Einsatz der intraaortalen Ballonpumpe bei Patienten mit kardiogenem Schock. Notfall Rettungsmed 14, 624–629 (2011). https://doi.org/10.1007/s10049-011-1415-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10049-011-1415-2
Schlüsselwörter
- Intraaortale Ballonpumpe
- Hämodynamik
- Kardiogener Schock
- Perkutane Koronarintervention
- IABP-Shock-II-Studie